Publication:
Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.

Loading...
Thumbnail Image

Date

2016

Authors

Boceta, J
De la Torre, A
Samper, D
Farto, M
Sánchez-de la Rosa, R

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

There is no unanimous consensus on the clinical features to define breakthrough cancer pain (BTcP). The current project aimed to investigate the opinion of a panel of experts on cancer pain on how to define, diagnose, assess, treat and monitor BTcP. A two-round Spanish multi-centre exploratory Delphi study was conducted with medical experts (n = 90) previously selected from Medical Oncology Services, Radiation Oncology, Palliative Care/Home Care Teams, and Pain Units. The study intended to seek experts' consensus and to define a set of recommendations for the management of BTcP. It was generally agreed that, definition of BTcP implies that baseline pain should be controlled (84 %), although not necessarily with opioids (only 30 %); there must be exacerbations (98.9 %); the duration of each episode should last The present Delphi study identified a set of recommendations to define, assess and monitor BTcP.

Description

MeSH Terms

Breakthrough Pain
Cancer Pain
Consensus
Delphi Technique
Pain Management

DeCS Terms

CIE Terms

Keywords

Baseline cancer pain, Breakthrough cancer pain, Cancer, Consensus, Delphi, Management

Citation